Clinical Trial Update: Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing albumin-bound interferon alfa-2b plus ribavirin to pegylated interferon alfa-2a plus ribavirin in interferon-naive patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Albumin Interferon Alfa-2b (Interferon alfa-2b (albumin-bound))
• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Human Genome Sciences Inc. | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED